Ayrton Drugs Manufacturing Company Ltd. announced earnings results for the first quarter ended September 30, 2018. For the first quarter, the company announced sales was GHS 6.566 million compared to GHS 9.003 million a year ago. Operating income was GHS 930,324 compared to GHS 1.646 million a year ago. Net income was GHS 384,450 compared to GHS 936,208 a year ago. Basic earnings per share was GHS 0.0018 compared to GHS 0.0044 a year ago.